Yesterday it was reported that the SVP, Global Mfg and Quality of Luminex (LMNX), Randall Myers, exercised options to sell 7,702 LMNX shares at $16.06 a share, for a total transaction value of $179.5K.
See today’s analyst top recommended stocks >>
Based on Luminex’s latest earnings report for the quarter ending December 31, the company posted quarterly revenue of $90.5 million and quarterly net profit of $3.32 million. In comparison, last year the company earned revenue of $81.13 million and had a GAAP net loss of $2.26 million. The company has a one-year high of $26.06 and a one-year low of $17.35. Currently, Luminex has an average volume of 281.37K.
The insider sentiment on Luminex has been negative according to 33 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.
Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Luminex Corp. develops, manufactures and markets proprietary biological testing technologies and products with applications throughout the life sciences and diagnostics industries. The company was founded by Mark B. Chandler and Van S. Chandler in May 1995 and is headquartered in Austin, TX.
